Author: Bella Hayes
Radnor, Pennsylvania–(Newsfile Corp. – December 29, 2024) – The law firm of Kessler Topaz Meltzer & Check, LLP (www.ktmc.com) informs investors that a securities class action lawsuit has been filed against Zeta Global (NYSE:) Holdings Corp. (“Zeta”) (NYSE: ZETA) on behalf of those who purchased or otherwise acquired Zeta securities between February 27, 2024, and November 13, 2024, inclusive (the “Class Period”). The lead plaintiff deadline is January 21, 2025. CONTACT KESSLER TOPAZ MELTZER & CHECK, LLP: If you suffered Zeta losses, you may CLICK HERE or go to: https://www.ktmc.com/new-cases/zeta-global-holdings-corp?utm_source=PR&utm_medium=link&utm_campaign=zeta&mktm=r You can also contact attorney Jonathan Naji, Esq. by calling…
U.Today – Dan Morehead, the founder and managing director of Pantera Capital, recently shared a bold, to say the least, vision for the future of (BTC). In a world where 300 million people already use cryptocurrency, he thinks the digital asset story is just beginning and the number of users is going to grow a lot, by even to 5 billion in the next 10 years. This kind of growth could totally reshape the financial landscape, and Bitcoin, the flagship cryptocurrency, is at the center of this transformation. Morehead’s analysis points to one striking possibility: Bitcoin’s market capitalization could hit…
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, continues to investigate potential securities claims on behalf of shareholders of Light & Wonder, Inc. (NASDAQ: NASDAQ:) resulting from allegations that Light & Wonder may have issued materially misleading business information to the investing public. SO WHAT: If you purchased Light & Wonder securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. The Rosen Law Firm is preparing a class action seeking recovery of investor losses. WHAT…
New York, New York–(Newsfile Corp. – December 29, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, announces that a shareholder has filed a class action on behalf of purchasers of Caribou Biosciences, Inc. (NASDAQ: CRBU) securities between July 14, 2023 and July 17, 2024, both dates inclusive (the “Class Period”). A class action has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than February 24, 2025. SO WHAT: If you purchased Caribou Biosciences securities during the Class Period you may be entitled to compensation without payment…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $100,000 In Warner Bros. Discovery (NASDAQ:) To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $100,000 in Warner Bros. Discovery between February 23, 2024 and August 7, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York–(Newsfile Corp. – December 29, 2024) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating…
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $75,000 In ™C To Contact Him Directly To Discuss Their Options If you suffered losses exceeding $75,000 in ™C between May 12, 2023 and March 25, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at 877-247-4292 or 212-983-9330 (Ext. 1310). [You may also click here for additional information] New York, New York–(Newsfile Corp. – December 29, 2024) – Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against ™C the…
New York, New York–(Newsfile Corp. – December 29, 2024) – Leading securities law firm Bleichmar Fonti & Auld LLP announces that it has filed a class actions lawsuit for violations of the federal securities laws against ASML Holding N.V. (NASDAQ: AS:) and certain of the Company’s senior executives. If you invested in ASML, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/asml-holding-nv. Investors have until January 13, 2025, to ask the Court to be appointed to lead the case. The complaint asserts claims under Sections 10(b) and 20(a) of the Securities Exchange Act of 1934 on behalf of investors…
By Laura Matthews NEW YORK (Reuters) -After closing the books on a banner year for U.S. stocks, investors expect to ride seasonal momentum into mid-January when a slew of economic data and a transition of power in Washington could send markets moving. The rose roughly 25% in 2024 through Dec. 27, while the technology-heavy Nasdaq Composite index (), which surpassed 20,000 for the first time in December, is up over 31%. On Friday, however, stocks sold off amid some profit taking and questions about how markets could perform in January, according to analysts and traders. “There are concerns that maybe…
Exclusive global license outside of Greater China for SHR-4849, a Phase 1 DLL3-targeting Topo-I-payload antibody drug conjugate (ADC)DLL3 highly expressed in Small Cell Lung Cancer (SCLC) and Neuroendocrine Tumors (NETs), respectively 85% and 20-40% Rational (LON:) combination opportunities with IDEAYA’s DNA Damage Repair ( DDR (NYSE:)) clinical pipeline, including Phase 1 PARG inhibitor IDE161Targeting US IND filing for SHR-4849 in H1 2025SOUTH SAN FRANCISCO, Calif. and SHANGHAI, Dec. 29, 2024 /PRNewswire/ — IDEAYA Biosciences (NASDAQ:), Inc. (NASDAQ: IDYA), a precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced that it has entered into an exclusive…
New York, New York–(Newsfile Corp. – December 28, 2024) – WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of common stock of Enphase Energy, Inc. (NASDAQ: NASDAQ:) between April 25, 2023 and October 22, 2024, both dates inclusive (the “Class Period”), of the important February 11, 2025 lead plaintiff deadline. SO WHAT: If you purchased Enphase common stock during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. WHAT TO DO NEXT: To join the Enphase Energy class action, go to…